Surface Oncology is a strong company with lots of big pharma ties. Had a brief run-up recently but was rejected by that .786 fib resistance level. Looking to break that level and see major growth this year. Target $22.88 for 182.65%. Like and follow for more biotech ideas :) Happy Trading!